republic-os/legislation/us/states/ca/20112012/ab-1277.md

---
type: "Bill"
title: "Sherman Food, Drug, and Cosmetic Law."
description: "The Sherman Food, Drug, and Cosmetic Law regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. The law prohibits the sale, delivery, or giving away of any new drug or new device unless either the department has approved a new drug or device application for that new drug or new device and that approval has not been withdrawn, terminated, or suspended or a new drug application has been approved for it and that approval has not been withdrawn, terminated, or suspended under specified provisions of the Federal Food, Drug, and Cosmetic Act, or it is a new device for which a premarket approval application has been approved, and that approval has not been withdrawn, terminated, or suspended under the federal act."
jurisdiction: "us/states/ca"
legislature: "California Legislature"
session: "20112012"
identifier: "AB 1277"
citation: "California AB 1277 (20112012)"
classification: ["bill"]
subjects: ["Sherman Food", "Drug", "and Cosmetic Law."]
status: "enacted"
primary_sponsors: ["Hill"]
version_count: 11
action_count: 34
vote_count: 7
first_action: "2011-02-18"
last_action: "2012-09-28"
source: "openstates"
source_identifier: "ocd-bill/b02c7824-5482-4d60-b662-b19a4c8963f0"
source_url: "http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=201120120AB1277"
source_hash: "1d28d579ce35b2f339213843406e34a2abe83bcb25fe7f589b37b79eb15e59ee"
vintage: "2026-07-01"
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
retrieved_at: "2026-07-06"
confidence: "reported"
tags: ["legislation", "bill", "us-ca"]
---

# California AB 1277 (20112012) — Sherman Food, Drug, and Cosmetic Law.

The Sherman Food, Drug, and Cosmetic Law regulates the packaging, labeling, and advertising of drugs and devices, and is administered by the State Department of Public Health. The law prohibits the sale, delivery, or giving away of any new drug or new device unless either the department has approved a new drug or device application for that new drug or new device and that approval has not been withdrawn, terminated, or suspended or a new drug application has been approved for it and that approval has not been withdrawn, terminated, or suspended under specified provisions of the Federal Food, Drug, and Cosmetic Act, or it is a new device for which a premarket approval application has been approved, and that approval has not been withdrawn, terminated, or suspended under the federal act.

## Version chain

The bill's text revisions, in order — the diff chain from filing to enrollment.

1. **02/18/11 - Introduced** (filed) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=201120120AB1277&version=20110AB127799INT)
2. **01/04/12 - Amended Senate** (committee substitute) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=201120120AB1277&version=20110AB127795AMD)
3. **03/31/11 - Amended Assembly** (committee substitute) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=201120120AB1277&version=20110AB127798AMD)
4. **04/13/11 - Amended Assembly** (committee substitute) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=201120120AB1277&version=20110AB127797AMD)
5. **06/20/12 - Amended Senate** (committee substitute) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=201120120AB1277&version=20110AB127794AMD)
6. **06/29/11 - Amended Senate** (committee substitute) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=201120120AB1277&version=20110AB127796AMD)
7. **07/05/12 - Amended Senate** (committee substitute) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=201120120AB1277&version=20110AB127793AMD)
8. **08/09/12 - Amended Senate** (committee substitute) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=201120120AB1277&version=20110AB127792AMD)
9. **09/28/12 - Chaptered** (committee substitute) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=201120120AB1277&version=20110AB127790CHP)
10. **AB1277** (committee substitute) — [source](http://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=201120120AB1277)
11. **08/31/12 - Enrolled** (enrolled) — [source](https://leginfo.legislature.ca.gov/faces/billPdf.xhtml?bill_id=201120120AB1277&version=20110AB127791ENR)

## Votes

- Do pass and be re-referred to the Committee on Business, Professions and Consumer Protection. — **17–0** (pass) · lower
- Do pass and re-refer to Committee on Appropriations with recommendation: To Consent Calendar. — **9–0** (pass) · lower
- Do pass, to Consent Calendar. — **16–0** (pass) · lower
- AB 1277 HILL Consent Calendar Second Day — **78–0** (pass) · lower
- Special Consent #16 AB1277 Hill By Rubio — **37–0** (pass) · upper
- AB 1277 HILL Concurrence in Senate Amendments — **80–0** (pass) · lower
- Do pass as amended, and re-refer to the Committee on Appropriations. — **7–0** (pass) · upper

## Sponsors

- Hill — primary (person)
- Alejo — coauthor (person)
- Blakeslee — coauthor (person)
- Fletcher — coauthor (person)
- Padilla — coauthor (person)
- Pan — coauthor (person)
- Perea — author (person)
- Smyth — coauthor (person)

## Timeline

The legislative action history — every referral, reading, and vote.

- **2011-02-18** Read first time. To print. `reading-1`
- **2011-02-20** From printer. May be heard in committee March 22.
- **2011-03-31** Referred to Coms. on HEALTH and B., P. & C.P. `referral-committee`
- **2011-03-31** From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. `reading-2, amendment-introduction, reading-1, amendment-passage`
- **2011-04-04** Re-referred to Com. on HEALTH. `referral-committee`
- **2011-04-13** From committee chair, with author's amendments: Amend, and re-refer to Com. on HEALTH. Read second time and amended. `reading-2, amendment-introduction, reading-1, amendment-passage`
- **2011-04-14** Re-referred to Com. on HEALTH. `referral-committee`
- **2011-04-27** From committee: Do pass and re-refer to Com. on B., P. & C.P. (Ayes 17. Noes 0.) (April 26). Re-referred to Com. on B., P. & C.P. `referral-committee, committee-passage, committee-passage-favorable`
- **2011-05-04** From committee: Do pass and re-refer to Com. on APPR. with recommendation: to consent calendar. (Ayes 9. Noes 0.) (May 3). Re-referred to Com. on APPR. `referral-committee, committee-passage, committee-passage-favorable`
- **2011-05-12** From committee: Do pass. To consent calendar. (Ayes 16. Noes 0.) (May 11). `committee-passage, committee-passage-favorable`
- **2011-05-16** Read second time. Ordered to consent calendar. `reading-2, reading-1`
- **2011-05-19** Read third time. Passed. Ordered to the Senate. (Ayes 78. Noes 0. Page 1453.) `reading-3, reading-1, passage`
- **2011-05-19** In Senate. Read first time. To Com. on RLS. for assignment. `reading-1`
- **2011-06-02** Referred to Com. on HEALTH. `referral-committee`
- **2011-06-15** In committee: Set, first hearing. Hearing canceled at the request of author.
- **2011-06-29** From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. `reading-2, amendment-introduction, reading-1, amendment-passage, referral-committee`
- **2011-07-05** In committee: Set, second hearing. Hearing canceled at the request of author.
- **2012-01-04** From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. `reading-2, amendment-introduction, reading-1, amendment-passage, referral-committee`
- **2012-06-11** In committee: Hearing postponed by committee.
- **2012-06-20** From committee chair, with author's amendments: Amend, and re-refer to committee. Read second time, amended, and re-referred to Com. on HEALTH. `reading-2, amendment-introduction, reading-1, amendment-passage, referral-committee`
- **2012-07-03** From committee: Do pass as amended and re-refer to Com. on APPR. (Ayes 7. Noes 0.) (June 27). `amendment-passage, committee-passage, committee-passage-favorable`
- **2012-07-05** Read second time and amended. Re-referred to Com. on APPR. `reading-2, reading-1, amendment-passage, referral-committee`
- **2012-08-06** From committee: Be placed on second reading file pursuant to Senate Rule 28.8. `committee-passage`
- **2012-08-07** Read second time. Ordered to third reading. `reading-2, reading-1`
- **2012-08-09** Read third time and amended. Ordered to second reading. `reading-3, reading-1, amendment-passage`
- **2012-08-13** Read second time. Ordered to third reading. `reading-2, reading-1`
- **2012-08-15** Ordered to special consent calendar.
- **2012-08-23** Read third time. Passed. Ordered to the Assembly. (Ayes 37. Noes 0. Page 4784.). `reading-3, reading-1, passage`
- **2012-08-24** In Assembly. Concurrence in Senate amendments pending. May be considered on or after August 28 pursuant to Assembly Rule 77.
- **2012-08-27** Assembly Rule 77 suspended. (Page 6357.)
- **2012-08-27** Senate amendments concurred in. To Engrossing and Enrolling. (Ayes 80. Noes 0. Page 6363.). `committee-passage-favorable, amendment-passage`
- **2012-09-05** Enrolled and presented to the Governor at 4:45 p.m.
- **2012-09-28** Approved by the Governor. `executive-signature`
- **2012-09-28** Chaptered by Secretary of State - Chapter 688, Statutes of 2012.

## Source

OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/b02c7824-5482-4d60-b662-b19a4c8963f0`. Confidence: reported (aggregated from official California legislature records).